The CorCal Outcomes trial found that using coronary artery calcium scans to guide statin prescriptions resulted in the same rate of major cardiovascular events as traditional risk assessments. However, the scan-based approach led to significantly fewer overall statin recommendations and much higher patient adherence to prescribed therapy.
This suggests that current risk calculators may miss many people who would benefit from treatment, while overtreat those who do not. The study does not prove the scan method is superior, but it highlights a gap in how we identify patients before their first heart attack.
more: https://www.sciencedaily.com/releases/2026/11/261105224604.htm
my other side: ivo.blogspot.com
Leave a Reply